2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Cited by (1,000)

Items 901–1,000 of 1,000

1. Molecular Therapeutics in Development to Treat Hyperlipoproteinemia
   Maud Ahmad, Robert Alexander Hegele · 2025 · Molecular Diagnosis & Therapy
2. Population-Level Screening for Diabetes and Dyslipidemia After Pregnancies Complicated by Hypertension or Diabetes
   Amy Yu, Nathalie Auger, Longdi Fu, Anna Chu, Moira K. Kapral, Jodi D. Edwards, Sonia R. Dancey, Peter C. Austin, Manav V. Vyas, Kara A. Nerenberg · 2025 · Circulation
3. The Relationship Between Regulatory Frameworks for Protein Content Claims for Plant Protein Foods and the Nutrient Intakes of Canadian Adults
   Songhee Back, Christopher P. F. Marinangeli, Antonio Rossi, Lamar Elfaki, Mavra Ahmed, Victoria Chen, Shuting Yang, A. Zurbau, Alison M Duncan, M. L'Abbé et al. · 2025 · Nutrients
4. Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm
   Latifah Alothman, Magdaline Zawadka, Sumayah Aljenedil, Mahesh Kajil, David J. Bewick, Daniel Gaudet, Robert Alexander Hegele, Eva Lonn, Daniel Ngui, Isabelle L. Ruel et al. · 2019 · CJC Open
5. The emerging role of proprotein convertase subtilisin/kexin type-9 inhibition in secondary prevention
   Amritanshu Shekhar Pandey, HARPREET SINGH BAJAJ, Vinay Garg, Avinash Pandey, Subodh Verma · 2017 · Current Opinion in Cardiology
6. Guideline Alignment in Related Areas
   Lisa Dubrofsky, Sheldon W. Tobe · 2019 · Canadian Journal of Cardiology
7. The 2018 ACC/AHA Lipid Guidelines: A Little More or Less Canadian?
   George Thanassoulis, Jean C. Grégoire, Glen J. Pearson · 2019 · Canadian Journal of Cardiology
8. Effect of PolyGlycopleX (PGX) Consumption on Blood Lipid Profiles in Healthy, Low CVD Risk Overweight Adults
   Vicky Ann Solah, Deborah Anne Kerr, Deasy Irawati, Wendy Hunt, Xingqiong Meng, Roland J. Gahler, Haelee Fenton, Stuart Keith Johnson, Anthony Paul James, Simon Wood · 2019 · Nutrients
9. Clinical Care for Individuals with Chronic Trypanosoma cruzi Infection: Decision-Making in the Midst of Uncertainty
   Juan Carlos Villar, Pablo Andrés Bermudez · 2019 · Birkhäuser advances in infectious diseases
10. CODAP: A multidisciplinary consensus among Portuguese experts on the definition, detection and management of atherogenic dyslipidemia
    Alberto Mello e Silva, Carlos Aguíar, João Sequeira Duarte, Luciana Couto, Manuel Teixeira Veríssimo, Pedro Marques da Silva · 2019 · Revista Portuguesa de Cardiologia (English Edition)
11. Relación del envejecimiento vascular saludable con los estilos de vida y el síndrome metabólico en población general española. Estudio EVA
    Marta Gómez‐Sánchez, Leticia Gómez‐Sánchez, María Carmen Patino-Alonso, Rosario Alonso‐Domínguez, Natalia Sánchez‐Aguadero, Jose Ignacio Recio-Rodriguez, Jesús González‐Sánchez, Luis García‐Ortiz, Manuel Ángel Gómez-Marcos · 2020 · Revista Española de Cardiología
12. Reduction in Stroke After Transient Ischemic Attack in a Province-Wide Cohort Between 2003 and 2015
    Ryan Wang, Arunima Kapoor, Patrice Lindsay, Cristina Goia, Amy Yu, David J. Gladstone, Richard H. Swartz · 2020 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
13. Effects and Issues of Diet Fat on Cardiovascular Metabolism
    Yasuhiro Nishikawa · 2020 · IntechOpen eBooks
14. Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers
    Alyssa M. B. White, Hillary R. Mishcon, John L. Redwanski, Ronald D. Hills · 2020 · Journal of Clinical Medicine
15. Real-world implementation of diabetes management by pharmacists: The R X ING Practice Tool
    Yazid N. Al Hamarneh, Hiroshi Okada, Ross T. Tsuyuki · 2021 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
16. Combining elements of the CO-OP Approach™ with education to promote healthy eating among older adults: A pilot study
    DEIRDRE R. DAWSON, Yael Bar, Fatim Ajwani, Shlomit Rotenberg, Barbara Atlas, Maria Ricupero, Carol Greewood, Matthew D. Parrott · 2022 · Frontiers in Rehabilitation Sciences
17. Development of ALOHa-G Risk Score for Detecting Postpartum Dyslipidemia Among Normoglycemic Women with Previous Gestational Diabetes: Observational Cohort Study
    Aleksandra Jotić, Milica M. Stoiljkovic, Tanja J. Milicic, Katarina S. Lalic, Ljiljana Z. Lukic, Marija V. Macesic, Jelena Stanarčić Gajović, Mina M. Milovancevic, Vedrana R. Pavlovic, Miroslava G. Gojnic et al. · 2023 · Diabetes Therapy
18. Development and Validation of Multiple Equations for Low-Density Lipoprotein and Apolipoprotein B in Korean Patients Visiting Local Clinics and Hospitals
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee · 2023 · Nutrients
19. Association of baseline serum cholesterol with benefits of intensive blood pressure control
    Xiaoqi Wang, Yingqing Feng, Li Yang, Guohui Zhang, Xiaoyuan Tian, Qianhui Ling, Jiang‐Shan Tan, Jun Cai · 2023 · Chinese Medical Journal
20. Efectos del valor de la marca de servicios en un marca de comida rápida en Nigeria.
    Tijani Usman Moyosore, Mustapha Tosin BALOGUN, Oyekunle Olubusola Temiloluwa · 2023 · IROCAMM-International Review Of Communication And Marketing Mix
21. Dyslipidaemia in Kidney Disease
    Charles Joseph Ferro · 2023 · Springer eBooks
22. Predictors of sustained physical activity: behaviour, bodily health, and the living environment
    Delia Elena Diaconaşu, Iulian Stoleriu, Ioana Andreea Câmpanu, Ana‐Maria Andrei, Ștefan Boncu, Cezar Honceriu, Veronica Mocanu, Georgiana Juravle · 2024 · Frontiers in Physiology
23. Joint Association of Lipoprotein(a) and a Family History of Coronary Artery Disease with the Cardiovascular Outcomes in Patients with Chronic Coronary Syndrome
    Huihui Liu, Sha Li, Yan Zhang, Yuan‐Lin Guo, Cheng‐Gang Zhu, Na‐Qiong Wu, Ying Gao, Rui‐Xia Xu, Qian Dong, Jian‐Jun Li · 2024 · Journal of Atherosclerosis and Thrombosis
24. Evaluation of the Influence of Hypolipidemic Medication on Albino Wistar Rats’ Bone Tissue by NMR Diffusiometry
    Emese Orban, Zsuzsanna Pap, Radu Fechete, Remus Sebastian Şipoş · 2024 · Medicina
25. Obésité centrale malgré un poids normal: Les dangers particuliers de la taille toxique
    N. John Bosomworth · 2019 · PubMed Central
26. Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): From Guidelines to Clinical Practice
    Omar Abdelfattah, Mohamed Hassanein, Anas M. Saad, George S. Abela, Saleh A. Aldasouqi · 2020 · Current Diabetes Reviews
27. Regional variability in Canadian routine care of type 2 diabetes, hypercholesterolemia, and hypertension: Results from the The Cardio-Vascular and metabolic treatments in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry
    Ronald Goldenberg, Alan Bell, Will Ho-Gi Cheng, Emilia Paron, Nadège Fils‐Aimé, Melonie Burrows, Jessica Blavignac, Maxime Barakat · 2020 · Journal of Cardiology
28. Mnemonic to assist in the treatment of NSTE-ACS
    Mohamed El Hussein, Jonah Hakkola · 2020 · The Nurse Practitioner
29. A Randomized, Placebo-controlled, Triple-blind Study to Determine the Effect of Farlong Ginseng Plus® NotoGinseng Extract on Cholesterol and Blood Pressure
    Malkanthi Evans, Erin Diane Lewis, David C. Crowley, Andy Zeng, Jing Struve, Najla Guthrie · 2021 · Current Nutraceuticals
30. Comparison Shopping: Guidelines for Statins for Primary Prevention of Cardiovascular Disease
    G.B. John Mancini · 2018 · Annals of Internal Medicine
31. Comment: Should an LDL Cholesterol Target–Based Approach Be Readopted?
    Ricky D. Turgeon, Glen J. Pearson · 2018 · Annals of Pharmacotherapy
32. Smashing Low-Density Lipoprotein Levels and Preventing Coronary Allograft Vasculopathy: One Heart Transplant Patient at a Time
    Aimee Noel, Jacques J. Genest · 2018 · Canadian Journal of Cardiology
33. Network medicine might lead to new treatments for dyslipidemia. It will be a challenging method to implement in a clinical context
    Moataz Dowaidar · 2021
34. Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
    Ishwarlal Jialal, Samuel T. Olatunbosun · 2023 · Journal of Clinical Medicine
35. Primary Prevention for Intermediate Risk
    Philip Greenland, Peter A. Glynn · 2024 · JACC Advances
36. The Burden of Cardiovascular Events According to Cardiovascular Risk Profile in Adults from High-, Middle- and Low-Income Countries
    Darryl P. Leong, PURE Investigators, Rita Yusuf, Romaina Iqbal, Álvaro Avezum, Afzalhussein Yusufali, Annika Rosengren, Jephat Chifamba, Fernando Tomas Lanas, Marı́a Luz Dı́az et al. · 2024 · medRxiv
37. The Power of Diet in CVD Risk Factor Reduction
    Wendy M. Jenkins, Amy E. Jenkins, Alexandra L. Jenkins, Caroline Brydson · 2019 · Elsevier eBooks
38. The Cardio-Vascular and Metabolic Treatments in Canada: Assessment of Real-Life Therapeutic Value Registry (CV-CARE): Registry Description and Baseline Patient Demographics
    Ronald Goldenberg, Willoon Cheng, Alan Bell, Melonie Burrows, Jessica Blavignac, Emilia Paron, Nadège Fils‐Aimé, Maxime Barakat · 2020 · Journal of Hypertension and Management
39. Exploring the Novelty in Lipid Profiling of Patients: A Non-fasting Approach from Eastern India
    Gautom Kumar Saharia, Saurav Nayak, Preetam Bhalchandra Mahajan, Manaswini Mangaraj · 2022 · Journal of Laboratory Physicians
40. Highlights of three metabolites HDL and reduction in blood pressure values after dietary fiber supplementation in overweight and obese normotensive women: a metabolomic study
    Cássia Surama Oliveira da Silva, Mussara Gomes Cavalcanti Alves Monteiro, Carla Patrícia Novaes dos Santos Fechine, Josean Fechine Tavares, Augusto Lopes Souto, Rafaella Cristhine Pordeus Luna, Flávia Cristina Fernandes Pimenta, Ana Hermínia Andrade e Silva, Alcides da Silva Diniz, Celso Costa da Silva Júnior et al. · 2023 · Metabolomics
41. Preeclampsia: Early and Long-Term Clinical Considerations
    Sarah Gibbs, Rachelle N. M. Govia, Jessica Cudmore, Laura Chisick, Robin Ducas · 2023 · Advances in biochemistry in health and disease
42. Does having a patient attend a postpartum vascular risk reduction clinic improve physician knowledge and management of preeclampsia as a cardiovascular risk factor?
    Jaslyn Rasmuson, Winnie W. Sia · 2024 · Obstetric Medicine
43. Inadequate awareness and attention to non-HDL cholesterol: undertreatment of high-risk patients in cardiology practice in Turkey
    Gurbet Özge Mert, Kadir Uğur Mert, Özcan Başaran, Volkan Doğan, İbrahim Rencüzoğulları, Bülent Özlek, Göksel Çinier, Eda Özlek, Murat Biteker, Meral Kayıkçıoğlu et al. · 2025 · Coronary Artery Disease
44. The Impact of Novel Lipid-Lowering Agents on Cardiovascular Risk Reduction: A Systematic Review and Meta-Analysis
    Rubela Ray, Arhum Mahmood, Raheel Chaudhry, Mohd Diya Masmoum, Muhammad Talha, Fahad I. Siddiqui, Imdad Ullah · 2025 · Current Cardiology Reviews
45. Dietary Patterns for Cardiometabolic Risk Reduction: Moving from Evidence to Implementation
    Laura Chiavaroli, Andrea J. Glenn, Meaghan E Kavanagh, Cyril W.C. Kendall, John L. Sievenpiper · 2025 · Springer eBooks
46. Assessment of the Utilization of Lipoprotein (a) and its Relationship with Cardiovascular Outcomes: A Retrospective Cohort Study from a Public Hospital in New York City
    Maisha Maliha, Natalia Nazarenko, Sanjana Nagraj, Vikyath Satish, Amrin Kharawala, Paweł Borkowski, Vibhor Garg, Tinatin Saralidze, Dimitrios Karamanis, Leonidas Palaiodimos · 2025 · Heart Views
47. Adapting a Self-Management Tool (My Kidneys My Health) to Meet the Needs of Diverse Canadian Populations: Program Report
    Maoliosa Donald, Sabrina Jassemi, Shannan Love, Gillian Crysdale, Dwight Sparkes, María Delgado, Laurinda Ferreira, Betty Pearson, Nancy Verdin, Kaitlin Ahrenholz et al. · 2025 · Canadian Journal of Kidney Health and Disease
48. Lipoprotein(a), ABO Blood Types and Clinical Outcomes: Novel Findings and Clinical Implications in Patients With Chronic Coronary Syndrome
    Hui‐Hui Liu, Chenxi Song, Sha Li, Yan Zhang, Dong Yin, Weihua Song, Yuan‐Lin Guo, Cheng‐Gang Zhu, Na‐Qiong Wu, Rui‐Xia Xu et al. · 2025 · MedComm
49. Statin therapy: time for a precision medicine approach?
    Albayda Mehdar, Robert Alexander Hegele, Richard B. Kim, Steven E. Gryn · 2017 · Expert Review of Precision Medicine and Drug Development
50. The ODYSSEY DM-DYSLIPIDEMIA trial: confirming the benefits of alirocumab in diabetic mixed dyslipidemia
    Paul Chan, Li Shao, Brian Tomlinson, Zhong-Min Liu · 2017 · Annals of Translational Medicine
51. RAISED LEVEL OF LIPOPROTEIDE(A) AS A PREDICTOR OF CARDIOVASCULAR COMPLICATION POST REVASCULARIZATION OF THE LOWER ExTREMETIES ARTERIES
    Narek A. Tmoyan, Olga I. Afanasieva, А. Е. Зотиков, Клесарева Елена Александровна, M. Abdulgamidov, Ежов Марат Владиславович, A V Pokrovsky, Sergei N. Pokrovsky · 2018 · Russian Journal of Cardiology
52. A Comparative Study of Muscle Symptoms of Atorvastatin with Rosuvastatin in Patients of Atherosclerotic Cardiovascular Disease
    Md Rakibul Hasan Rashed, Subhash Banerjee, Syed Ali Ahsan, SM Mustafa Zaman, Khurshed Ahmed, Md Mukhlesur Rahman, Manzoor Mahmood, Jahanara Arzu, Dipal Krishna Adhikary, Md Golam Hossain Rabbani et al. · 2018 · University Heart Journal
53. Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients
    Kamlesh K. Khunti, Hyejung Jung, Antonio L Dans, Claes Held, Gilles R. Dagenais, Salim Yusuf, Eva Lonn · 2019 · Canadian Journal of Cardiology
54. Development of a cost-effective CVD prediction model using lifestyle factors. A cohort study in Pakistan
    Parveen Naheeda, Khan Sharifullah, Shah Saeed Ullah, Abbas Muhammad Azeem, Younis Shahzad, Waqar Kinza · 2020 · African Health Sciences
55. Real-world effectiveness of treatments for type 2 diabetes, hypercholesterolemia, and hypertension in Canadian routine care – Results from the CardioVascular and metabolic treatment in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry, 12-months results
    Ronald Goldenberg, Alan Bell, Willoon Cheng, Nadège Fils‐Aimé, Melonie Burrows, Jessica Blavignac, Emilia Paron, Maxime Barakat · 2020 · Diabetes Research and Clinical Practice
56. Genetic Disorders of Lipoprotein Metabolism
    Alan S. Brown, Ehab G. Dababneh, Adib M. Chaus, Vadzim Chyzhyk, Victor Marinescu, Nataliya Pyslar · 2020 · Contemporary cardiology
57. Switching of Hormone Therapies in Breast Cancer Women
    Luana Moreira de Medeiros, Rebeca Stahlschmidt, Amanda Canato Ferracini, Cinthia Madeira de Souza, Cássia Raquel Teatin Juliato, Priscila Gava Mazzola · 2021 · Revista Brasileira Ginecologia e Obstetrícia
58. Approach to: Type 2 diabetes management
    Susan Joanne Wang · 2021 · McGill Journal of Medicine
59. Impact of the 2016 Canadian Lipid Guidelines on Daily Practice at a Community Hospital
    Louis-Jacques Cartier, Alex Robin, Simon St-Cœur, Mathieu Lagacé, Donaldo D. Canales, Pierre Douville · 2021 · Canadian Journal of Diabetes
60. New-onset type 2 DM risk in dyslipidemia and stroke patients due to simvastatin use
    Ema Pristi Yunita, Widya Pratiwi Suryanti, Didi Candradikusuma · 2021 · Journal Of Advanced Pharmacy Education And Research
61. Minimum pathology reporting standard for gastro-intestinal cancers in Nigeria: A draft proposal
    DE Obaseki, Fatimah Biade Abdulkareem, O Rotimi, Olufemi John Ogunbiyi, SO Oluwasola, OS Ojo, BM Duduyemi, UO Igbokwe · 2013 · Nigerian Journal of Gastroenterology and Hepatology
62. The design and rationale of the Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE) study
    Junran J. Peng, Navid Saleh, Thomas M. Roston, Adam I. Kramer, Lubomira Cermakova, G.B. John Mancini, Christopher B. Fordyce, Liam R. Brunham · 2022 · American Heart Journal Plus Cardiology Research and Practice
63. Female Fitness Members: Meaningful Targets for Psycho-somatic and Behavioural Investigation
    2018 · Journal of Psychiatry and Behaviour Therapy
64. Stroke Risk Factor Profile in an Urban Population: A Community-Based Descriptive Study in Mojo Sub-District, Surabaya, Indonesia
    Ilham Ikhtiar, Mochammad Wijdan Rosyich, Muhammad Arief Ardhanu, Dewi Setyaning Bastiana, Dedy Kurniawan, Sita Setyowatie · 2023 · AKSONA
65. Nutraceuticals and Functional Foods for Cholesterol Reduction
    David J.A. Jenkins, Laura Chiavaroli, Arash Mirrahimi, Kristie Srichaikul, Julia MW Wong, Peter J.H. Jones, Darshna K. Patel, Cyril W.C. Kendall, John L. Sievenpiper · 2023 · Elsevier eBooks
66. Developing and Evaluating Data Infrastructure and Implementation Tools to Support Cardiometabolic Disease Indicator Data Collection
    Mohammadreza Amiri, Suban Kangatharan, Louise Brisbois, Farnoosh Farahani, Natavan Khasiyeva, Meredith Burley, B. Catharine Craven · 2023 · Topics in Spinal Cord Injury Rehabilitation
67. Increased Lp(a) Workload Volumes Reflect Uptake of the 2021 Canadian Cardiovascular Society Guidelines for Management of Dyslipidemia
    Dennis J. Orton, Jessica L. Gifford, Joshua E. Raizman, Glen J. Pearson, Albert K.Y. Tsui · 2024 · Canadian Journal of Cardiology
68. Impact of a Medical Fitness Model on Incident Major Adverse Cardiovascular Events: A Prospective Cohort Study of 11 000 Members
    Ranveer Brar, Reid H. Whitlock, Alan Katz, Michelle Di Nella, Paul V. J. Komenda, Clara J Bohm, Claudio Rigatto, Navdeep Tangri, Carrie Solmundson, David Collister · 2024 · Journal of the American Heart Association
69. The Influence of Non-High-Density Lipoprotein Cholesterol on the Efficacy of Genotype-Guided Dual Antiplatelet Therapy in Preventing Stroke Recurrence
    Qin Xu, Xia Meng, Hao Li, Xuewei Xie, Jing Jing, Jinxi Lin, Yong Jiang, Yilong Wang, Xingquan Zhao, Zixiao Li et al. · 2024 · Journal of Stroke
70. Does LDL-C determination method affect statin prescribing for primary prevention? A register-based study in Southern Denmark
    Anton Pottegård, Lars Ulrik Gerdes, Jakob Langballe Wetche, Wade Thompson · 2024 · European Heart Journal - Cardiovascular Pharmacotherapy
71. Small apolipoprotein(a) isoforms may predict primary patency following peripheral arterial revascularization
    Marianna Pavlyha, Madeleine D Hunter, Roman Nowygrod, Virenda I. Patel, Nicholas J. Morrissey, Danielle R. Bajakian, Yihao Li, Gissette Reyes‐Soffer · 2024 · JVS Vascular Science
72. Studying the local anaesthetic effects of lidocaine, remifentanil (with and without adjuvants), and tramadol in rabbits
    Nabaa Fadhil Abbas, Raffal A. Omar · 2024 · Journal of Research in Pharmacy
73. Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease
    Diana N. Vikulova, May Kuen Lee, Karin H. Humphries, Danielle Pinheiro-Muller, Martin G. Dawes, Simon Neil Pimstone, Liam R. Brunham · 2024 · JACC Advances
74. Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions
    Hasanga D. Manikpurage, Jérôme Bourgault, Ursula Houessou, Audrey Paulin, Pardis Zamani, Éloi Gagnon, Zhonglin Li, Dominique K. Boudreau, Aïda Eslami, Pierre Voisine et al. · 2025 · Communications Medicine
75. Lipid‐lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic
    Katerina Kiburg, Glenn M. Ward, David Norman O'Neal, Richard J. MacIsaac · 2018 · Internal Medicine Journal
76. Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk
    Dominic Mitchell, Jason R. Guertin, Jacques LeLorier · 2018 · Molecular Diagnosis & Therapy
77. Dyslipidaemias and Cardiovascular Disease: Focus on the Role of PCSK9 Inhibitors
    Όλγα Παναγιωτοπούλου, Scott T. Chiesa, Dimitrios M. Tousoulis, Marietta Charakida · 2019 · Current Medicinal Chemistry
78. New Trends Approved in Management of Dyslipidaemia
    Abdulaziz Aboshahba · 2019 · Journal of Cardiology & Cardiovascular Therapy
79. Statin-Associated Muscle Symptoms Are Real
    Peter Paul Toth · 2020 · Contemporary cardiology
80. The Canadian Consensus Working Group’s Approach to Identifying and Managing Statin-Associated Muscle and Other Symptoms
    G.B. John Mancini, Jean Bergeron, DAVID H. FITCHETT, Jacques J. Genest, Milan Gupta, Robert Alexander Hegele, Dominic S. Ng, Glen J. Pearson, Janet Elizabeth Pope · 2020 · Contemporary cardiology
81. Pregnancy Risks and Women’s Future Cardiovascular Health: Needs Assessment of Primary Care Physicians’ Knowledge and Practices
    Karen Fleming, Shivani Bhat, Aakriti Pyakurel · 2021 · Canadian Family Physician
82. Association of common gene-smoking interactions with elevated plasma apolipoprotein B concentration
    Nathalie Roy, Daniel Gaudet, Gérald Tremblay, Diane Brisson · 2020 · Lipids in Health and Disease
83. Baseline, delta, and achieved low‐density lipoprotein cholesterol levels and cardiovascular risk in patients on statin therapy: A post‐hoc resampling mediation analysis of treating new targets [TNT] trial
    Myung Han Hyun, Jae Won Jang, Eun Mi Lee, Hyonggin An, Hong Seog Seo · 2020 · Clinical and Experimental Pharmacology and Physiology
84. Statin Initiation: Guideline Concordance and Characteristics of New Users in Quebec, Canada
    Sarasa M.A. Johnson, Manon Choinière, Michèle Bally, Marie‐Pierre Dubé, Jean‐Claude Tardif, Daniel Gaudet, Jean Bergeron, Hélène Lanctôt, Jacques LeLorier · 2020 · Journal of Population Therapeutics and Clinical Pharmacology
85. C-Reactive Protein and Other Inflammatory Markers in Cardiovascular Disease: Inflammatory Disorders and Atherosclerosis
    Eric J. Brandt · 2020 · Contemporary cardiology
86. Management strategies for STE-ACS
    Mohamed Toufic El Hussein, Jonah Hakkola · 2021 · The Nurse Practitioner
87. Review of the top 5 cardiology studies of 2019-20
    Arden R. Barry, Hazal E. Babadagli, Rosaleen Boswell, June W. Chen, Ellen L. Dawson, David G. Lopaschuk, Chloe L. McMillan, Binh V. Nguyen, Mohamed A. Omar, Dylan M. Pollmann et al. · 2021 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
88. Physical Activity and Nutrition in Chronic Kidney Disease
    Heather Waters, Michele MacDonald Werstuck · 2022 · Springer eBooks
89. Rupturas de aneurisma de la aorta abdominal: técnicas específicas
    Joseph Touma, Côme Bosse, Jean Marzelle, Pascal Desgranges, Frédéric Cochennec · 2021 · EMC - Cirugía General
90. The Biofield Energy Treatment and its Effect on the Relative Oral Bioavailability of Lovastatin Hydroxy Acid in Rats after a Single Oral Dose of Lovastatin
    Snehasis Jana · 2021 · Bioequivalence & Bioavailability International Journal
91. Approche de la stratification du risque de maladies cardiovasculaires athéroscléreuses
    Daniel Esau, Beth L. Abramson · 2022 · Canadian Family Physician
92. Management of Stable Angina: A Treatment Strategy Mnemonic
    Mohamed Toufic El Hussein, Jonah Hakkola · 2023 · The Journal for Nurse Practitioners
93. Effective Management of Cardiovascular Risk Factors—Are We Doing Enough?
    Koon Kang Teo, Hisham Dokainish · 2016 · Canadian Journal of Cardiology
94. Seeking ‘meta guidelines’ for lipids
    William A. Dafoe, Robert Alexander Hegele · 2016 · European Journal of Preventive Cardiology
95. Bringing Structure to the Art of Lipid-Lowering Therapy
    Todd J. Anderson · 2016 · Journal of the American College of Cardiology
96. Precision of nonfasting lipid profiles should focus on clinical relevance rather than necessarily obtaining the least variation
    Børge Grønne Nordestgaard, Michel R. Langlois · 2017 · Clinical Chemistry and Laboratory Medicine (CCLM)
97. The Cat Has 9 Lives, Until it Dies
    Jacques J. Genest, Dong-Vu Nguyen · 2019 · Journal of the American College of Cardiology
98. Primary Care Provider’s Perspectives on Physical Activity Counseling
    Laura K. Easty · 2018 · TSpace (University of Toronto)
99. Addressing atherosclerotic cardiovascular disease risk in South Asians: A daunting task ahead
    Milan Gupta · 2020 · Atherosclerosis
100. Non-HDL-C is associated with the occurrence of acute myocardial infarction in Chinese populations with diabetes
     Yixin Tang, Chen Chen, Hua Su, Zhenwang Tang, Jianbo Yue, Xiaotian Luo, Changhui Liu · 2022 · Research Square